Swiss HLG’s Post

🌟 LSX World Congress – 𝗗𝗮𝘆 𝟭: 𝗨𝗻𝗹𝗲𝗮𝘀𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵! 🌟 🌱 Today, Ken C., Life Sciences Counsel at the London office, attended the LSX World Congress, where he connected with fascinating biotech companies during partner meetings and where he attended inspiring panel discussions. 🚀 Ablynx and Galapagos: Two names that echoed across the room. These companies, hailing from Flanders, have proven that, contrary to popular belief, 𝐭𝐡𝐞 𝐩𝐚𝐭𝐡 𝐭𝐨 𝐭𝐫𝐢𝐮𝐦𝐩𝐡 𝐢𝐧 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐢𝐬𝐧’𝐭 𝐬𝐨𝐥𝐞𝐥𝐲 𝐩𝐚𝐯𝐞𝐝 𝐰𝐢𝐭𝐡 𝐚 𝐟𝐢𝐫𝐬𝐭 𝐥𝐢𝐬𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒. Their Flemish beginnings paved the way for global triumphs! 📈 Flanders was their starting point. Both Ablynx and Galapagos made their 𝐝𝐞𝐛𝐮𝐭 𝐨𝐧 𝐁𝐞𝐥𝐠𝐢𝐚𝐧 𝐬𝐭𝐨𝐜𝐤 𝐞𝐱𝐜𝐡𝐚𝐧𝐠𝐞𝐬 𝐛𝐞𝐟𝐨𝐫𝐞 𝐞𝐦𝐛𝐚𝐫𝐤𝐢𝐧𝐠 𝐨𝐧 𝐭𝐡𝐞𝐢𝐫 𝐠𝐥𝐨𝐛𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. And guess what? Their strategic moves paid off! 🔍 Ablynx: Acquired by Sanofi after making waves in Flanders. 📊 Galapagos: Soared to the Nasdaq, captivating investors worldwide. 👀 Looking forward to 𝗗𝗮𝘆 𝟮!

Last call for early bird savings: 24th BioEquity Europe. ✅ Register (or apply to present) by Friday, Feb. 9 to save: https://lnkd.in/gSxxhu7 What is Bio€quity? 🔹 Bio€quity Europe is a destination event for VCs and biopharma decision-makers. 🔹 This year we will gather in San Sebastián, Spain, Basque Country, to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent. Why attend? ➣ Debate how to stand out from the crowd and reach the discussion stage with investors and #pharma. ➣ Meet VCs, CEOs, and BD&L leaders in an intimate setting designed for networking and discussion. ➣ Discover 100+ emerging biotechs selected for the Presenting Company Track. ➣ Dive into European biotech trends with an exclusive conference report from Insights Partner McKinsey & Company. ➣ Build stronger connections with investors and CEOs during the pre-event networking excursions – pintxos tour, wine tasting, golf, and more.  ➣ Schedule one-to-one meetings; check out the Poster Session; take your conversation outside, onto the beach. Don't wait to register. Last year, BioEquity sold out. I hope to see you there! P.S. On behalf of BioCentury Inc. and EBD Group, many thanks to everyone supporting the event, including Regional Host Chair Ysios Capital; Founding Sponsor Sofinnova Partners; Talent Showcase Sponsor Johnson & Johnson; R&D Sponsor ICON plc + Bioqube Ventures, Syncona Limited , UCB Ventures, VIB and many more. #venturecapital #biotech #biopharma #drugdevelopment #businessdevelopment

Calluna Pharma is attending Bio€quity Europe conference, taking place 12-14 May, organized by BioCentury Inc. and EBD Group. Our CEO John Montana is going to be in San Sebastian next week for one of Europe’s top experiences for CEOS and investors to network, partner and discuss key issues facing the biotech industry. This is an opportunity to learn more about how to reach discussion stage with investors, discover 100+ emerging biotechs, and dive into European biotech trends. Find out more, and join us here: https://lnkd.in/dzunkQc #Biotech #Pharma #VentureCapital #BioEquityEurope #BioEquity

Advanced Registration is ending soon for the 24th Bio€quity Europe. ⏳ This year we meet in San Sebastián, Spain, Basque Country, to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent. To frame the discussion, Insights Partner McKinsey & Company returns for the fifth time with an exclusive conference report on the European biotech ecosystem. Recent successful IPOs, business development and M&A activities have boosted optimism in the #biotech community. Yet, an increasing number of biotechs are competing for available wallets and partnership opportunities. ➤ How can biotechs successfully differentiate and ‘rise above the noise’? ➤ How can investors and business development teams deploy their capital efficiently, identifying future ‘winners’ early? Register for #BioEquityEurope by April 2 to save: https://ow.ly/ETpg50R2ppi To view the agenda and a list of attendees, please download the conference brochure: https://ow.ly/MKTq50R2ppj

Only 3 weeks until the 24th BioEquity Europe in San Sebastian, Spain. Please register now -- before it sells out! Partnering is open, 130+ biotechs confirmed to present, only a few slots left on our pre-event networking excursions (first-come, first-served). ✅ Register: https://lnkd.in/gSxxhu7 ✳️ One area to highlight -> This year's agenda focuses on: How can #biotechs "rise above the noise" to attract the right investors, partners and talent? Recent additions to the faculty, include: ➢ Arjen Lemmen of argenx ➢ Arno de Wilde of EQT Group ➢ Caroline Gaynor of Lightstone Ventures ➢ Christina Takke of V-Bio Ventures ➢ Claire Brown of Oxford Science Enterprises ➢ Dmitry 'Dima' Kuzmin of 4BIO Capital ➢ Elise Peters of Syncona Limited ➢ Florent Gros of Earlybird Venture Capital ➢ Franck Le Deu of McKinsey & Company ➢ Frank Kalkbrenner of Boehringer Ingelheim ➢ Jason P. Hafler of Sanofi ➢ Joep Muijrers of Gilde Healthcare ➢ Jonathan Tobin of Brandon Capital ➢ Karen Wagner of Ysios Capital ➢ Ksenija Pavletic of JEITO ➢ Nerida Scott of Johnson & Johnson ➢ Nina Rawal of Trill Impact ➢ Paulo Fontoura of Roche ➢ Dr. Shanshan Xu of BioNTech SE ➢ Søren Møller of Novo Nordisk And many more... I hope you will join BioCentury and EBD Group at this destination event for #biotech CEOs and investors. No event has a larger concentration of VCs than BioEquity. Please DM me if you have any questions. See you soon in San Sebastian! #venturecapital #drugdevelopment #biopharma #BioEquityEurope

🌟 Exciting News Alert! 🌟 Thrilled to announce that Zuzanna Szklarz and Dominika Kulpińska will be representing ClinMark at the prestigious Swiss Biotech Day! 🇨🇭 Join us at our stand for engaging discussions, networking opportunities, and to explore the latest advancements in clinical research. See you there! #SwissBiotechDay #ClinMark #ClinicalResearch #Networking #IndustryInsights

Exciting News! Pitching Start-ups at Global Investor Forum! 🚀   🎉 We're thrilled to announce that Sherif Idriss of Elastin Biosciences Ltd will be pitching at Global Investor Forum! 🌍✨   🚀 About Elastin Biosciences: Elastin Biosciences is a spin-off from Longaevus Technologies. They have pioneered a first-in-class Elastin-restoration platform technology, using small molecules. Using a single therapeutic and a combination-therapy approach, they have shown for the first time increased elastin expression in vivo combined with improved aortic structural integrity and function. Their technology has huge implications for elastin-deficiency diseases, as well as a huge potential for a wide range of applications.   🔍 Read more about Elastin Bioscience & Sherif Idriss: https://lnkd.in/ePYe8pdy   👏 Join us: Are you a start-up wanting to pitch your company for investors and other key players in the industry? Or are you an investor looking to meet innovative companies? Join us at I4H Global Investor Forum.   Save the date 🗓️ 27 March 2024 📍Loyens & Loeff office Rotterdam 🔗https://lnkd.in/eGyCCcH

🌟 Exciting Reflections from COG Nordics 2024! 🌟 Last week, I had the pleasure of chairing a C-Suite panel at the COG Nordics conference in #Copenhagen, diving deep into the intricacies of funding for Nordic clinical-stage #biotechs. Joined by industry #leaders from MyCural Therapeutics, Alder Therapeutics, Amplio Pharma, and Node Pharma, we explored essential strategies to navigate the complex landscape of investment funding for clinical trials. Key Takeaways: - Early-Stage Funding: The critical role of securing initial resources can significantly impact the success and progress of clinical trials. - Expert Guidance: Leveraging expert advice is vital for bridging the communication gap between scientists and investors. - Networking: The importance of building robust connections within industry events to foster potential investment and collaboration opportunities. - Track Record: Establishing a credible and successful history to attract and reassure investors. Missed out on this insightful discussion? Don’t worry! Join us for our next meeting in Amsterdam this November for more enriching experiences. 🌍 Read Here: https://lnkd.in/efwYKWtT 📈 #Biotech #ClinicalTrials #InvestmentFunding #NordicBiotech #COGNordics2024 #HealthcareInnovation #ProfessionalNetworking

As the opportunity to translate breakthrough innovation in biotech into products for patients, remains stronger than ever, it is admirable to see leaders like Ricardo Perdigão Henriques, PhD develop robust, but right-sized investment platforms in underserved markets in Europe. Risk capital is THE critical ingredient to creating a true entrepreneurial culture at the local level. Without sophisticated investors, who know how to pick winners and build companies, it is way too difficult to overcome the huge risks of commercializing biotech products. #innovation #venturecapital #riskreward #entrepreneurship #leadership #culture #emergingmarkets #collaboration #teamwork #strategy

Looking forward to the BioTech company presentations and being inspired by the high level of innovation at this level! These conferences are always great for seeing what the future holds for patient populations who still have a high unmet need. Paola Valinotti's advice is just what these assets need to understand what is required to generate a successful outcome, further down the line. And at FINGERPOST, we're happy to bring the research, data, clinical and payer experts together to support Paola and others to deliver this. #marketaccess #pricing #forwardthinking #SwissBiotechDay